Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease

Rheumatology (Oxford). 2022 Oct 6;61(10):e302-e304. doi: 10.1093/rheumatology/keac298.
No abstract available

MeSH terms

  • COVID-19 Vaccines* / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Immunization, Secondary* / adverse effects
  • Musculoskeletal Diseases*
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines

Supplementary concepts

  • COVID-19 vaccine booster shot